|1.||Stanley, E Richard: 8 articles (08/2009 - 09/2002)|
|2.||West, Brian L: 2 articles (01/2015 - 01/2014)|
|3.||Barreda, Daniel R: 2 articles (11/2014 - 04/2013)|
|4.||Rieger, Aja M: 2 articles (11/2014 - 04/2013)|
|5.||Hamilton, John A: 2 articles (04/2012 - 01/2012)|
|6.||Menke, Julia: 2 articles (01/2012 - 08/2009)|
|7.||Schwarting, Andreas: 2 articles (01/2012 - 08/2009)|
|8.||Kelley, Vicki R: 2 articles (01/2012 - 08/2009)|
|9.||Toy, Eugene P: 2 articles (09/2011 - 01/2005)|
|10.||Chambers, Setsuko K: 2 articles (09/2011 - 01/2005)|
10/01/2013 - "We used an inhibitor of the CSF-1 receptor (CSF-1R) to target TAMs in a mouse proneural GBM model, which significantly increased survival and regressed established tumors. "
09/01/2011 - "The c-fms proto-oncogene encoded CSF-1 receptor and its ligand represent a feedback loop, which in a paracrine manner, is well known to promote spread of breast cancers. "
02/18/2010 - "CSF-1 receptor (CSF1R) signaling is important for the recruitment of CD11b(+)F4/80(+) tumor-associated macrophages (TAMs) and contributes to myeloid cell-mediated angiogenesis. "
02/18/2010 - "Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy."
12/09/1999 - "The CSF-1 receptor (CSF-1R) is expressed in >50% of human breast cancers. "
|2.||Melanoma (Melanoma, Malignant)
|3.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2005 - "Utilizing an intraperitoneal model for metastatic spread with BT20 human breast carcinoma cells, clonally expanded cells expressing five fold higher c-fms protein were compared with parent BT20 cells as well as an underexpressing clone using intrasplenic injection following left flank cut-down in female nude and Severe combined immunodeficient (SCID) mice. "
01/01/1997 - "Breast carcinomas express wild-type CSF-1 receptors (CSF-1R) at levels comparable to those observed in trophoblast and monocytes. "
02/01/1995 - "Breast carcinomas express wild-type CSF-1 receptors at levels comparable to those observed in trophoblast and monocytes. "
02/01/2004 - "Recent research found abnormal expression of the c-fms oncogene, which encodes the macrophage colony-stimulating factor receptor (CSF-1R), in several human carcinomas including hepatocellular carcinoma (HCC). "
07/01/2008 - "The prognostic impact of M-CSF, CSF-1 receptor, CD68 and CD3 in prostatic carcinoma."
06/01/2002 - "The expression, characterization and roles of macrophage colony-stimulating factor receptor in human leukemia cell lines."
09/01/2001 - "Decreased serum soluble macrophage colony stimulating factor receptor level in leukemia patients."
02/01/1998 - "Establishment of a human leukemia HL-60 cell line that expresses high levels of M-CSF receptors."
02/15/1992 - "Functional expression of the macrophage colony-stimulating factor receptor in human THP-1 monocytic leukemia cells."
12/01/1988 - "Thus, constitutive activation of the CSF-1 receptor gene, either by mutation or gene rearrangement, might be expected to contribute to leukemia."
|1.||Macrophage Colony-Stimulating Factor
|3.||4- cyano- N- (2- (1- cyclohexen- 1- yl)- 4- (1- ((dimethylamino)acetyl)- 4- piperidinyl)phenyl)- 1H- imidazole- 2- carboxamide
|4.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
|5.||Messenger RNA (mRNA)
|6.||Epidermal Growth Factor Receptor (EGF Receptor)
|7.||Proto-Oncogene Proteins c-fyn
|8.||Interleukin-6 (Interleukin 6)
|9.||Mifepristone (RU 486)
|10.||RNA (Ribonucleic Acid)